|
Market Closed -
Nasdaq
16:00:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 0.9604 USD | +1.09% |
|
+9.82% | -28.86% |
| 11-04 | Ocugen, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-04 | Ocugen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCUGEN, INC. | Other Biotechnology & Medical Research | +1.09% | +9.82% | -28.86% | -27.79% | -88.95% | 322M |  |  | |
- Stock Market
- Stocks
- OCGN Stock
- Charts Ocugen, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
